| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8780032 | Gynecologic Oncology | 2018 | 6 Pages | 
Abstract
												Hysterectomy as a first-line treatment is effective without salvage chemotherapy in 82.4% of women with low-risk non-metastatic GTN and can be presented as an alternative to single-agent chemotherapy when childbearing considerations have been fulfilled. In young patients, this therapeutic option should not be considered because single-agent chemotherapies are curative in nearly 100% of patients while maintaining fertility.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Obstetrics, Gynecology and Women's Health
												
											Authors
												Pierre-Adrien Bolze, Mélodie Mathe, Touria Hajri, Benoit You, Yohann Dabi, Anne-Marie Schott, Sophie Patrier, Jérôme Massardier, François Golfier, 
											